Need relief from asthma? Communicating with your allergist is key – EurekAlert (press release)


Jagran Post

Need relief from asthma? Communicating with your allergist is key
EurekAlert (press release)
ARLINGTON HEIGHTS, Ill. (January 13, 2014) – Can't find relief from your asthma symptoms? The way you communicate with your allergist can be the root of your problems. According to two papers published in the January issue of Annals of Allergy, Asthma 
Have asthma? Don't shy away from your doctorDaijiworld.com
Communicate more with your docs for better asthma treatmentJagran Post

all 11 news articles »

View full post on asthma – Google News

Have asthma? Don’t shy away from your doctor – Daijiworld.com


Jagran Post

Have asthma? Don't shy away from your doctor
Daijiworld.com
New York, Jan 13 (IANS): Can't find relief from asthma symptoms? Grill your doctor frequently to better understand your problem, says a study. In order for asthma treatment to be effective, patients need to increase communication with their physicians
Communicate more with your docs for better asthma treatmentJagran Post

all 11 news articles »

View full post on asthma – Google News

Need Relief from Asthma? Communicating With Your Allergist Is Key – Science Daily (press release)


India.Com Health

Need Relief from Asthma? Communicating With Your Allergist Is Key
Science Daily (press release)
Jan. 13, 2014 — Can't find relief from your asthma symptoms? The way you communicate with your allergist can be the root of your problems. According to two papers published in the January issue of Annals of Allergy, Asthma and Immunology, in order for 
Have asthma? Don't shy away from your doctorDaily News & Analysis

all 10 news articles »

View full post on asthma – Google News

Need relief from asthma? Communicating with your allergist is key – Medical Xpress


IANS

Need relief from asthma? Communicating with your allergist is key
Medical Xpress
Can't find relief from your asthma symptoms? The way you communicate with your allergist can be the root of your problems. According to two papers published in the January issue of Annals of Allergy, Asthma and Immunology, in order for treatment to be 
Have asthma? Don't shy away from your doctorDaily News & Analysis

all 6 news articles »

View full post on asthma – Google News

A Single-Nucleotide Polymorphism of Human Neuropeptide S Gene Originated from Europe Shows Decreased Bioactivity.

Related Articles

A Single-Nucleotide Polymorphism of Human Neuropeptide S Gene Originated from Europe Shows Decreased Bioactivity.

PLoS One. 2013;8(12):e83009

Authors: Deng C, He X, Hsueh AJ

Abstract
Using accumulating SNP (Single-Nucleotide Polymorphism) data, we performed a genome-wide search for polypeptide hormone ligands showing changes in the mature regions to elucidate genotype/phenotype diversity among various human populations. Neuropeptide S (NPS), a brain peptide hormone highly conserved in vertebrates, has diverse physiological effects on anxiety, fear, hyperactivity, food intake, and sleeping time through its cognate receptor-NPSR. Here, we report a SNP rs4751440 (L(6)-NPS) causing non-synonymous substitution on the 6(th) position (V to L) of the NPS mature peptide region. L(6)-NPS has a higher allele frequency in Europeans than other populations and probably originated from European ancestors ?25,000 yrs ago based on haplotype analysis and Approximate Bayesian Computation. Functional analyses indicate that L(6)-NPS exhibits a significant lower bioactivity than the wild type NPS, with ?20-fold higher EC50 values in the stimulation of NPSR. Additional evolutionary and mutagenesis studies further demonstrate the importance of the valine residue in the 6(th) position for NPS functions. Given the known physiological roles of NPS receptor in inflammatory bowel diseases, asthma pathogenesis, macrophage immune responses, and brain functions, our study provides the basis to elucidate NPS evolution and signaling diversity among human populations.

PMID: 24386135 [PubMed – as supplied by publisher]

View full post on pubmed: asthma

Toluene diisocyanate emission to air and migration to a surface from a flexible polyurethane foam.

Related Articles

Toluene diisocyanate emission to air and migration to a surface from a flexible polyurethane foam.

Ann Occup Hyg. 2013 Jun;57(5):650-61

Authors: Vangronsveld E, Berckmans S, Spence M

Abstract
Flexible polyurethane foam (FPF) is produced from the reaction of toluene diisocyanate (TDI) and polyols. Because of the potential for respiratory sensitization following exposure to TDI, concerns have been raised about potential consumer exposure to TDI from residual ‘free TDI’ in FPF products. Limited and conflicting results exist in the literature concerning the presence of unreacted TDI remaining in FPF as determined by various solvent extraction and analysis techniques. Because residual TDI results are most often intended for application in assessment of potential human exposure to TDI from FPF products, testing techniques that more accurately simulated human contact with foam were designed. To represent inhalation exposure to TDI from polyurethane foam, a test that measured the emission of TDI to air was conducted. For simulation of human dermal exposure to TDI from polyurethane foam, a migration test technique was designed. Emission of TDI to air was determined for a representative FPF using three different emission test cells. Two were commercially available cells that employ air flow over the surface of the foam [the Field and Laboratory Emission Cell (FLEC®) and the Micro-Chamber/Thermal Extraction™ cell]. The third emission test cell was of a custom design and features air flow through the foam sample rather than over the foam surface. Emitted TDI in the air of the test cells was trapped using glass fiber filters coated with 1-(2-methoxyphenyl)-piperazine (MP), a commonly used derivatizing agent for diisocyanates. The filters were subsequently desorbed and analyzed by liquid chromatography/mass spectrometry. Measurement of TDI migration from representative foam was accomplished by placing glass fiber filters coated with MP on the outer surfaces of a foam disk and then compressing the filters against the disk using a clamping apparatus for periods of 8 and 24 h. The sample filters were subsequently desorbed and analyzed in the same manner as for the emission tests. Although the foam tested had detectable levels of solvent-extractable TDI (56ng TDI g(-1) foam for the foam used in emissions tests; 240-2800ng TDI g(-1) foam for the foam used in migration tests), no TDI was detected in any of the emission or migration tests. Method detection limits (MDLs) for the emissions tests ranged from 0.03 to 0.5ng TDI g(-1) foam (0.002-0.04ng TDI cm(-2) of foam surface), whereas those for the migration tests were 0.73ng TDI g(-1) foam (0.16ng TDI cm(-2) of foam surface). Of the three emission test methods used, the FLEC® had the lowest relative MDLs (by a factor of 3-10) by virtue of its high chamber loading factor. In addition, the FLEC® cell offers well-established conformity with emission testing standard methods.

PMID: 23680588 [PubMed – indexed for MEDLINE]

View full post on pubmed: asthma

Study: Dogs may keep kids from getting asthma, allergies – fox2now.com


UCSF News Services

Study: Dogs may keep kids from getting asthma, allergies
fox2now.com
LOUIS, MO (KTVI)– Doctors at Saint Louis University say dogs may not only be “man's best friend”, they may keep children from developing asthma and allergies later in life. Researchers exposed mice to dust from a dog owner's home then tested the mice's 
How Dogs Might Protect Kids Against Asthma: Gut BacteriaWall Street Journal
Research Shows How Household Dogs Protect Against Asthma and InfectionUCSF News Services
How household dogs protect against asthma and infectionScience Daily (press release)
Philly.com –PBS NewsHour
all 66 news articles »

View full post on asthma – Google News